What is the current Price Target for the Reviva Pharmaceuticals Holdings Inc. stock?

The average Reviva Pharmaceuticals Holdings Inc. target price is $3.06. This is 506.90% higher than the current stock price. The highest price target is 1,982.51%, the lowest is 300.63%. 9 Analysts have issued a price target Reviva Pharmaceuticals Holdings Inc. 2026 .

How high will the Reviva Pharmaceuticals Holdings Inc. stock rise?

No reliable answer can be given as to how high the Reviva Pharmaceuticals Holdings Inc. stock will rise. The performance of stocks, including the Reviva Pharmaceuticals Holdings Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Reviva Pharmaceuticals Holdings Inc. stock today?

The performance of Reviva Pharmaceuticals Holdings Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Reviva Pharmaceuticals Holdings Inc. stock fall?

The decline in Reviva Pharmaceuticals Holdings Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Reviva Pharmaceuticals Holdings Inc. Forecast, price target & analysts

$0.50

0.82% yesterday

Nasdaq, Nov 07, 10:19 pm CET

ISIN

US76152G1004

Symbol

RVPH

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Reviva Pharmaceuticals Holdings Inc. Target price 2025 - Analyst rating & recommendation

Reviva Pharmaceuticals Holdings Inc. Classifications & Recommendation:

Buy

92%

Hold

Reviva Pharmaceuticals Holdings Inc. Price Target

Target Price	$3.06
Price	$0.50
Potential	506.90% register free of charge
Number of Estimates	9

	9 Analysts have issued a price target Reviva Pharmaceuticals Holdings Inc. 2026 . The average Reviva Pharmaceuticals Holdings Inc. target price is $3.06. This is 506.90% register free of charge higher than the current stock price. The highest price target is $10.50 1,982.51% register free of charge , the lowest is $2.02 300.63% register free of charge .
	A rating was issued by 13 analysts: 12 Analysts recommend Reviva Pharmaceuticals Holdings Inc. to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Reviva Pharmaceuticals Holdings Inc. stock has an average upside potential 2026 of 506.90% register free of charge . Most analysts recommend the Reviva Pharmaceuticals Holdings Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-0.90	-0.45
	45.45%	50.00%
P/E		negative

10 Analysts have issued a Reviva Pharmaceuticals Holdings Inc. forecast for earnings per share. The average Reviva Pharmaceuticals Holdings Inc. EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-0.90	45.45%
2025	$-0.45 50.00% Unlock
2026	$-0.36 20.00% Unlock
2027	$-0.32 11.11% Unlock
2028	$-0.07 78.13% Unlock
2029	$-0.06 14.29% Unlock
2030	$0.47 883.33% Unlock
2031	$1.75 272.34% Unlock
2032	$2.24 28.00% Unlock

Current	-0.93	6.39%
2025	-1.11 18.88% Unlock
2026	-1.42 27.93% Unlock
2027	-1.57 10.56% Unlock
2028	-7.06 349.68% Unlock
2029	-8.99 27.34% Unlock
2030	1.07 111.90% Unlock
2031	0.29 72.90% Unlock
2032	0.22 24.14% Unlock

Reviva Pharmaceuticals Holdings Inc....

Current Reviva Pharmaceuticals Holdings Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
D. Boral Capital	Locked ➜ Locked	Locked	Oct 28 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Oct 27 2025
Chardan Capital	Locked ➜ Locked	Locked	Sep 29 2025
D. Boral Capital	Locked ➜ Locked	Locked	Sep 19 2025
Benchmark	Locked ➜ Locked	Locked	Sep 15 2025
D. Boral Capital	Locked ➜ Locked	Locked	Aug 18 2025
Roth Capital	Locked ➜ Locked	Locked	Aug 18 2025

Analyst Rating	Date
Locked D. Boral Capital: Locked ➜ Locked	Oct 28 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Oct 27 2025
Locked Chardan Capital: Locked ➜ Locked	Sep 29 2025
Locked D. Boral Capital: Locked ➜ Locked	Sep 19 2025
Locked Benchmark: Locked ➜ Locked	Sep 15 2025
Locked D. Boral Capital: Locked ➜ Locked	Aug 18 2025
Locked Roth Capital: Locked ➜ Locked	Aug 18 2025

Discover more stocks with a high price target

Novo Nordisk 60.25%

TUI 59.01%

Adidas 53.11%

Deutsche Telekom 45.39%

Meta Platforms (Facebook) 43.56%

Adyen 39.97%

BYD 38.89%

BioNTech SE - ADR 34.99%

Coinbase Global, Inc. 33.30%

Infineon 30.91%

Microsoft 29.34%

Netflix 28.46%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now